Tapewire

Nasdaq · USD

JAGX

Jaguar Health, Inc.

Export transactions ↓
Tapewire entity
8387
SEC CIK
0001585608
Parsed reports
179

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 19, 2016 Filed Dec 21, 2016 14:34 UTC
MICEK JOHNDirector
GrantStock Option (right to buy) · Derivative 10,884 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001104659-16-163177 · a4.xml · derivative · entry 1

MICEK JOHN · CIK 0001243187 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,884

Underlying: Common Stock · 10,884 shares

Expires 2026-12-19

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on January 19, 2017, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
December 19, 2016 Filed Dec 21, 2016 14:27 UTC GrantStock Option (right to buy) · Derivative 16,378 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001104659-16-163173 · a4.xml · derivative · entry 1

BOCHNOWSKI JAMES J · CIK 0001255743 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,378

Underlying: Common Stock · 16,378 shares

Expires 2026-12-19

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on January 19, 2017, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
December 19, 2016 Filed Dec 21, 2016 19:41 UTC
Waltzman Roger J.Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 2,866 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001104659-16-163180 · a4.xml · derivative · entry 1

Waltzman Roger J. · CIK 0001678987 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,866

Underlying: Common Stock · 2,866 shares

Expires 2026-12-19

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan.

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on January 19, 2017, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
December 19, 2016 Filed Dec 21, 2016 19:35 UTC
King Steven R.Executive VP and Secretary
GrantStock Option (right to buy) · Derivative 4,496 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001104659-16-163178 · a4.xml · derivative · entry 1

King Steven R. · CIK 0001622052 · Executive VP and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,496

Underlying: Common Stock · 4,496 shares

Expires 2026-12-19

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on January 19, 2017, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
December 19, 2016 Filed Dec 21, 2016 19:31 UTC GrantStock Option (right to buy) · Derivative 13,771 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001104659-16-163175 · a4.xml · derivative · entry 1

Kamphuis Folkert W. · CIK 0001644201 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,771

Underlying: Common Stock · 13,771 shares

Expires 2026-12-19

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on January 19, 2017, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
September 22, 2016 Filed Sep 23, 2016 14:59 UTC
CONTE LISA ADirector · CEO and President
GrantStock Option (right to buy) · Derivative 318,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001104659-16-146279 · a4.xml · derivative · entry 1

CONTE LISA A · CIK 0001008377 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,000

Underlying: Common Stock · 318,000 shares

Expires 2026-09-22

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on October 22, 2016, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
September 22, 2016 Filed Sep 23, 2016 15:00 UTC
Wright Karen SteilChief Financial Officer
GrantStock Option (right to buy) · Derivative 103,698 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001104659-16-146280 · a4.xml · derivative · entry 1

Wright Karen Steil · CIK 0001310280 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,698

Underlying: Common Stock · 103,698 shares

Expires 2026-09-22

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on October 22, 2016, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
September 22, 2016 Filed Sep 23, 2016 15:47 UTC GrantStock Option (right to buy) · Derivative 75,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001104659-16-146289 · a4.xml · derivative · entry 1

BOCHNOWSKI JAMES J · CIK 0001255743 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2026-09-22

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on October 22, 2016, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
September 22, 2016 Filed Sep 26, 2016 16:00 UTC
King Steven R.Executive VP and Secretary
GrantStock Option (right to buy) · Derivative 23,042 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001104659-16-146472 · a4.xml · derivative · entry 1

King Steven R. · CIK 0001622052 · Executive VP and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,042

Underlying: Common Stock · 23,042 shares

Expires 2026-09-22

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on October 22, 2016, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
September 22, 2016 Filed Sep 26, 2016 14:54 UTC GrantStock Option (right to buy) · Derivative 13,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001104659-16-146458 · a4.xml · derivative · entry 1

Kamphuis Folkert W. · CIK 0001644201 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2026-09-22

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan

F2 · derivative.exercise_date: Vests in equal monthly installments, beginning on October 22, 2016, such that it is vested in full on the 3-year anniversary of the grant date.

Read SEC document
August 12, 2016 Filed Nov 14, 2016 16:19 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.47 $0.00
Disclosure

SEC source: 0001104659-16-156685 · a4.xml · derivative · entry 1

Kamphuis Folkert W. · CIK 0001644201 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2026-08-12

F1 · security: Granted pursuant to the Issuer's 2014 Equity Incentive Plan.

F2 · derivative.exercise_date: 100% vested on the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.